Literature DB >> 14504204

High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer.

Rachel E Ellsworth1, Darrell L Ellsworth, Susan M Lubert, Jeff Hooke, Richard I Somiari, Craig D Shriver.   

Abstract

Capillary array electrophoresis and laser-assisted microdissection, which provide increased speed and accuracy in loss of heterozygosity studies, are often used independently in studying breast cancer; the successful coupling of these emerging technologies, however, must overcome technical problems, especially those related to the poor quality and quality of DNA typically retrieved from archival tumor samples. Here we present a panel of 52 microsatellite markers from 26 of the most commonly deleted regions in breast cancer. All markers have been optimized to robustly amplify DNA extracted from paraffin-embedded samples, represent informative (highly polymorphic) loci, and effectively detect chromosomal loss. In the 10 tumor samples (stage 0 to stage III) tested here, chromosomal loss was detected loss for every locus, and the degree of loss at the 26 commonly deleted regions ranged from 23% to 77%. This panel can be used to quickly detect genomic patterns of loss in large numbers of breast tumor samples and may provide both clinical information and molecular information regarding the underlying tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504204

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

Review 1.  Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.

Authors:  Thomas P Ahern; Daniel L Hertz; Per Damkier; Bent Ejlertsen; Stephen J Hamilton-Dutoit; James M Rae; Meredith M Regan; Alastair M Thompson; Timothy L Lash; Deirdre P Cronin-Fenton
Journal:  Am J Epidemiol       Date:  2016-12-17       Impact factor: 4.897

2.  Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system.

Authors:  Christopher M Heaphy; William C Hines; Kimberly S Butler; Christina M Haaland; Glenroy Heywood; Edgar G Fischer; Marco Bisoffi; Jeffrey K Griffith
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 3.  Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.

Authors:  Deirdre P Cronin-Fenton; Per Damkier; Timothy L Lash
Journal:  Future Oncol       Date:  2014-01       Impact factor: 3.404

4.  Genomic instability demonstrates similarity between DCIS and invasive carcinomas.

Authors:  Christopher M Heaphy; Marco Bisoffi; Nancy E Joste; Kathy B Baumgartner; Richard N Baumgartner; Jeffrey K Griffith
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

5.  Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Brad Love; Darrell L Ellsworth; Craig D Shriver
Journal:  Pathol Oncol Res       Date:  2009-02-05       Impact factor: 3.201

6.  Molecular alterations associated with breast cancer mortality.

Authors:  Laura M Voeghtly; Kim Mamula; J Leigh Campbell; Craig D Shriver; Rachel E Ellsworth
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

Review 7.  Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.

Authors:  Samuel J Rodgers; Daniel T Ferguson; Christina A Mitchell; Lisa M Ooms
Journal:  Biosci Rep       Date:  2017-02-10       Impact factor: 3.840

8.  Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma.

Authors:  Rick Jordan; Satish Patel; Hai Hu; James Lyons-Weiler
Journal:  Cancer Inform       Date:  2008-07-14

9.  Amplification of HER2 is a marker for global genomic instability.

Authors:  Rachel E Ellsworth; Darrell L Ellsworth; Heather L Patney; Brenda Deyarmin; Brad Love; Jeffrey A Hooke; Craig D Shriver
Journal:  BMC Cancer       Date:  2008-10-14       Impact factor: 4.430

10.  Fingerprinting lymph node metastases.

Authors:  W Fraser Symmans; Gabriel N Hortobagyi
Journal:  Ann Surg Oncol       Date:  2008-03-14       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.